Swiss Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.15 Cr
- Paid Up Capital ₹ 1.11 Cr
- Company Age 38 Year, 30 Days
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 28.10 Cr
- Satisfied Charges ₹ 6.79 Cr
- Revenue Growth -12.55%
- Profit Growth -57.53%
- Ebitda -16.82%
- Net Worth 2.68%
- Total Assets -5.34%
About Swiss Pharma
Swiss Pharma Pvt Ltd (SPPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 23 January 1987 and has a history of 38 years. Its registered office is in Ahmedabad, Gujarat, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.15 Cr and a paid-up capital of Rs 1.11 Cr.
The company currently has active open charges totaling ₹28.10 Cr. The company has closed loans amounting to ₹6.79 Cr, as per Ministry of Corporate Affairs (MCA) records.
Sharadchandra Shah and Darshan Shah serve as directors at the Company.
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24231GJ1987PTC009343
- Company No.
009343
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
23 Jan 1987
- Date of AGM
17 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
What products or services does Swiss Pharma Pvt Ltd offer?
Swiss Pharma Pvt Ltd offers a wide range of products and services, including Hair Care, Hair Growth for Men.
Who are the key members and board of directors at Swiss Pharma?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Darshan Shah  | Managing Director | 01-Sep-2019 | Current |
| Sharadchandra Shah | Managing Director | 23-Jan-1987 | Current |
Board Members
No Directors or KMP associated with company. Upon reviewing the records, we can confirm that there are no Directors or Key Management Personnel (KMP) associated with this company at present.
Financial Performance of Swiss Pharma.
Swiss Pharma Pvt Ltd, for the financial year ended 2024, experienced significant reduction in revenue, with a 12.55% decrease. The company also saw a substantial fall in profitability, with a 57.53% decrease in profit. The company's net worth moved up by a moderate rise of 2.68%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Swiss Pharma?
In 2024, Swiss Pharma had a public holding of 1.22%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Swiss Sterile Private LimitedSharadchandra Shah and Darshan Shah are mutual person
- Sapphire Medicare Private Limited
Sharadchandra Shah and Darshan Shah are mutual person
- Nuven Industries Llp
Darshan Shah is a mutual person
- Swipha Exports Private Limited
Darshan Shah is a mutual person
Charges (Loans)
₹28.10 Cr
₹6.79 Cr
Charges Breakdown by Lending Institutions
- Bank Of India : 26.40 Cr
- Others : 1.70 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 13 Sep 2024 | Others | ₹1.70 Cr | Open |
| 05 Apr 2021 | Bank Of India | ₹6.10 M | Open |
| 07 May 1994 | Bank Of India | ₹12.89 Cr | Open |
| 25 Aug 1992 | Bank Of India | ₹12.90 Cr | Open |
| 07 Jul 2018 | Bank Of India | ₹7.00 M | Satisfied |
How Many Employees Work at Swiss Pharma?
Swiss Pharma has a workforce of 50 employees as of Feb 10, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Swiss Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Swiss Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
